Medicare Enrolled
Dr. Jyoti Ganguly, M.D.
Cardiovascular Disease · Smithtown, NY
Practice pattern: Cardiac & Electrophysiology
— Practice combining cardiac and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ganguly from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ganguly?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ganguly
Dr. Jyoti Ganguly is a cardiovascular disease specialist in Smithtown, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ganguly performed 2,857 Medicare services across 2,115 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ganguly received a total of $8,633 from 38 pharmaceutical and/or device companies across 338 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ganguly is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 33% volume in NY
$8,633 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,857
Medicare services
Top 33% in NY for cardiovascular disease
2,115
Unique beneficiaries
$97
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~150 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
593 | $108 | $300 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
555 | $13 | $200 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
320 | $46 | $100 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
224 | $180 | $1,900 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
216 | $7 | $52 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
198 | $182 | $1,175 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
158 | $95 | $400 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
91 | $58 | $425 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
88 | $72 | $770 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
80 | $403 | $3,000 |
| Aminophylline injection, up to 250 mg Administration of aminophylline medication via injection for a dose of up to 250 mg. |
64 | $6 | $25 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
62 | $132 | $472 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
60 | $120 | $1,490 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
37 | $192 | $2,410 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
27 | $65 | $625 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
25 | $109 | $1,110 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 24 | $418 | $1,000 |
| PET scan of heart muscle blood flow A nuclear medicine imaging test that uses positron emission tomography (PET) to evaluate blood flow within the heart muscle. |
12 | $127 | $300 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
12 | $1,226 | $5,000 |
| Emergency department visit, moderate complexity An emergency department visit for an established or new patient involving a moderate level of medical decision making. |
11 | $112 | $1,270 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.8% high complexity
32.3% medium
59.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,633
Total received (2018-2024)
Avg $1,233/year across 7 years
Top 23% in NY for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
338
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,633 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,876
2023
$756
2022
$1,542
2021
$1,426
2020
$1,216
2019
$928
2018
$889
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
CVRx, Inc.
$342
Novartis Pharmaceuticals Corporation
$279
Boehringer Ingelheim Pharmaceuticals, Inc.
$253
E.R. Squibb & Sons, L.L.C.
$200
Daiichi Sankyo Inc.
$195
Abbott Laboratories
$118
PFIZER INC.
$93
Janssen Pharmaceuticals, Inc
$51
Novo Nordisk Inc
$43
Philips North America LLC
$39
Merck Sharp & Dohme LLC
$39
SCPHARMACEUTICALS INC.
$38
Edwards Lifesciences Corporation
$30
Baxter Healthcare
$27
SANOFI-AVENTIS U.S. LLC
$24
La Jolla Pharmaceutical Company
$24
Inspire Medical Systems, Inc.
$23
Boston Scientific Corporation
$21
Esperion Therapeutics, Inc.
$20
ATRICURE, INC.
$18
Top 3 companies account for 46.6% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$1,430
Novartis Pharmaceuticals Corporation
$1,026
Boehringer Ingelheim Pharmaceuticals, Inc.
$832
E.R. Squibb & Sons, L.L.C.
$658
Amgen Inc.
$577
CVRx, Inc.
$546
PFIZER INC.
$505
Medtronic Vascular, Inc.
$476
Janssen Pharmaceuticals, Inc
$428
Esperion Therapeutics, Inc.
$218
Edwards Lifesciences Corporation
$201
Daiichi Sankyo Inc.
$195
SANOFI-AVENTIS U.S. LLC
$174
Merck Sharp & Dohme LLC
$168
Astellas Pharma US Inc
$152
Amarin Pharma Inc.
$142
AstraZeneca Pharmaceuticals LP
$133
Allergan Inc.
$96
Merck Sharp & Dohme Corporation
$65
Braemar Manufacturing, LLC
$46
ARBOR PHARMACEUTICALS, INC.
$46
Novo Nordisk Inc
$43
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$41
Philips North America LLC
$39
Kestra Medical Technology Services, Inc.
$38
La Jolla Pharmaceutical Company
$38
SCPHARMACEUTICALS INC.
$38
Medtronic, Inc.
$37
Gilead Sciences, Inc.
$37
Chiesi USA, Inc.
$32
Lundbeck LLC
$30
Baxter Healthcare
$27
Kiniksa Pharmaceuticals, Ltd.
$23
Inspire Medical Systems, Inc.
$23
Boston Scientific Corporation
$21
BOSTON SCIENTIFIC CORPORATION
$21
ATRICURE, INC.
$18
HeartFlow, Inc.
$12
Top 3 companies account for 38.1% of all-time payments
Associated products mentioned in payments ›
(5091) Amb Mon & Diag Und · (CM9) Amb Mon & Diag Und · Arcalyst · Assure WCD · Azure · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CARDIOMEMS · CHANTIX · CLEVIPREX · Cardiac Monitoring Suite · CardioMEMS HF System · Confirm Rx · Corlanor · ELIQUIS · ENTRESTO · Edarbi · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FFRct · FUROSCIX · HeartMate · HeartMate 3 Left Ventricular Dev · Hillrom - Carnation Ambulatory Monitor · INJECTAFER · INSPIRE · JARDIANCE · JOT DX · KENGREAL · LEQVIO · LEXISCAN · LINQ II · Lexiscan · LifeVest · MITRACLIP · MULTAQ · Mitra Clip system · MitraClip System · NEXLETOL · NEXLIZET · NORTHERA · Ozempic · PRADAXA · PRALUENT · Pacemakers · Ranexa · Repatha · Reveal LINQ · SAPIEN 3 Ultra RESILIA · SYNERGY ABLATION SYSTEM · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · VERQUVO · Vascepa · WATCHMAN · WATCHMAN FLX · Wegovy · XARELTO · XERAVA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
349
Per 100K population
22.9
County median income
$128,329
Nearest hospital
ST CATHERINE OF SIENA HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ganguly is a cardiac & electrophysiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ganguly experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Ganguly performed 593 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ganguly receive payments from pharmaceutical companies?
Yes. Dr. Ganguly received a total of $8,633 from 38 companies across 338 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ganguly's costs compare to other cardiologists in Smithtown?
Dr. Ganguly's average Medicare payment per service is $97. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ganguly) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Smithtown
Browse cardiologists in Smithtown ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in NY
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in NY
Which NY cardiologists receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology